Alger Life Sciences Innovation Fund LP
About
Issuer
- Entity type
- Limited Partnership
- Jurisdiction
- Delaware
- Sector
- Services
- Headquarters
- New York, NY
- Street
- 100 Pearl Street, 27th Floor
- Zip
- 10004
Offering
- Total offering
- —
- Amount sold
- $30.3M
- First sale
- May 20, 2022
- Min investment
- $500k
- Securities
- Pooled investment fund
- Federal exemption
- Rule 506(b)
- Investors so far
- 13
How this filing compares
Other New York filings this week: 1791 Capital Partners Evergreen Fund, LP, 1791 Capital Partners, LP, 2E Select Credit Onshore Fund, LP, AG Kai Bo Realty, L.P., ALGER DYNAMIC RETURN FUND LLC
Leadership
N/A Alger Alternative Holdings II, LLC — Promoter
N/A Fred Alger Management, LLC — Promoter
Daniel Cayley Chung — Executive Officer (also: Director)
Also named on: ALGER DYNAMIC RETURN FUND LLC, Alger Life Sciences Innovation Offshore Fund, LP, Weatherbie Long/Short Fund, L.P., WEATHERBIE GROWTH FUND LP
Hal Liebes — Executive Officer (also: Director)
Also named on: ALGER DYNAMIC RETURN FUND LLC, Alger Life Sciences Innovation Offshore Fund, LP, Weatherbie Long/Short Fund, L.P., WEATHERBIE GROWTH FUND LP
Robert Louis Kincel — Executive Officer (also: Director)
Also named on: ALGER DYNAMIC RETURN FUND LLC, Alger Life Sciences Innovation Offshore Fund, LP, Weatherbie Long/Short Fund, L.P., WEATHERBIE GROWTH FUND LP
Filing details
Alger Life Sciences Innovation Fund LP filed a Form D with the SEC on April 10, 2026.